RAPT Therapeutics, Inc. (RAPT)

RAPT Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	169.74	47.48	38.95	24.03	24.92
Short-Term Investments	61.32	111.38	210.12	165.63	86.59
Cash & Short-Term Investments	231.06	158.86	249.07	189.65	111.51
Cash Growth	45.44%	-36.22%	31.33%	70.08%	44.10%
Prepaid Expenses	4.18	2.92	3.63	3.32	4.09
Total Current Assets	235.24	161.78	252.69	192.97	115.6
Property, Plant & Equipment	4.7	7.68	9.48	2.74	2.98
Other Long-Term Assets	0.39	3.87	4.04	2.92	0.39
Total Assets	240.33	173.33	266.21	198.64	118.97
Accounts Payable	1.28	5.18	3.37	2	2.38
Accrued Expenses	44.6	14.1	8.66	6.33	4.94
Current Portion of Leases	2.42	2.45	2.17	-	-
Current Unearned Revenue	-	-	-	1.02	4.1
Other Current Liabilities	0.06	0.11	0.03	0.25	0.33
Total Current Liabilities	48.35	21.84	14.22	9.6	11.74
Long-Term Leases	2.07	4.46	6.82	-	-
Long-Term Unearned Revenue	-	-	-	0.51	0.86
Other Long-Term Liabilities	-	-	-	2.15	2.19
Total Liabilities	50.42	26.29	21.04	12.26	14.79
Common Stock	0.01	0	0	0	0
Additional Paid-In Capital	804.39	631.61	613.07	470.63	319.2
Retained Earnings	-614.55	-484.68	-367.88	-284.05	-214.84
Comprehensive Income & Other	0.05	0.1	-0.03	-0.21	-0.18
Total Common Equity	189.9	147.04	245.17	186.38	104.18
Shareholders' Equity	189.9	147.04	245.17	186.38	104.18
Total Liabilities & Equity	240.33	173.33	266.21	198.64	118.97
Total Debt	4.49	6.91	8.99	-	-
Net Cash (Debt)	226.56	151.96	240.08	189.65	111.51
Net Cash Growth	49.10%	-36.71%	26.59%	70.08%	44.10%
Net Cash Per Share	5.56	3.96	7.38	6.92	4.62
Filing Date Shares Outstanding	132.01	34.8	34.29	29.57	24.87
Total Common Shares Outstanding	132.01	34.4	34.25	29.56	24.77
Working Capital	186.89	139.95	238.47	183.38	103.86
Book Value Per Share	1.44	4.27	7.16	6.31	4.21
Tangible Book Value	189.9	147.04	245.17	186.38	104.18
Tangible Book Value Per Share	1.44	4.27	7.16	6.31	4.21
Machinery	8.15	8.52	7.49	7.13	6.77
Leasehold Improvements	3.3	3.3	3.3	3.3	3.29

Updated Mar 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q